000			01985 a2200505 4500
005			20250515124602.0
264		0	_c20081003
008			200810s 0 0 eng d
022			_a0724-8741
024	7		_a10.1007/s11095-008-9596-1 _2doi
040			_aNLM _beng _cNLM
100	1		_aZrieki, Afraa
245	0	0	_aCyclooxygenase inhibitors down regulate P-glycoprotein in human colorectal Caco-2 cell line. _h[electronic resource]
260			_bPharmaceutical research _cSep 2008
300			_a1991-2001 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aATP Binding Cassette Transporter, Subfamily B
650	0	4	_aATP Binding Cassette Transporter, Subfamily B, Member 1 _xantagonists & inhibitors
650	0	4	_aATP Binding Cassette Transporter, Subfamily G, Member 2
650	0	4	_aATP-Binding Cassette Transporters _xgenetics
650	0	4	_aAntineoplastic Agents _xpharmacology
650	0	4	_aCaco-2 Cells
650	0	4	_aCelecoxib
650	0	4	_aColorectal Neoplasms _xdrug therapy
650	0	4	_aCyclooxygenase 1 _xmetabolism
650	0	4	_aCyclooxygenase 2 _xmetabolism
650	0	4	_aCyclooxygenase 2 Inhibitors _xpharmacology
650	0	4	_aDinoprostone _xmetabolism
650	0	4	_aDown-Regulation
650	0	4	_aDrug Resistance, Neoplasm _xdrug effects
650	0	4	_aGene Expression Regulation, Neoplastic _xdrug effects
650	0	4	_aHumans
650	0	4	_aIndomethacin _xanalogs & derivatives
650	0	4	_aNaproxen _xpharmacology
650	0	4	_aNeoplasm Proteins _xgenetics
650	0	4	_aPyrazoles _xpharmacology
650	0	4	_aRNA, Messenger _xmetabolism
650	0	4	_aReproducibility of Results
650	0	4	_aSulfonamides _xpharmacology
650	0	4	_aTime Factors
700	1		_aFarinotti, Robert
700	1		_aBuyse, Marion
773	0		_tPharmaceutical research _gvol. 25 _gno. 9 _gp. 1991-2001
856	4	0	_uhttps://doi.org/10.1007/s11095-008-9596-1 _zAvailable from publisher's website
999			_c18064702 _d18064702